Cyclophosphamide causes nausea and vomiting in 60-90% of patients. Whi
lst the initiating factor of the emesis produced by cyclophosphamide i
s unknown, biotransformation of the drug has important consequences on
emetic potency. At least 30 degradation products of cyclophosphamide
have been identified but it is unclear which of these contributes to e
mesis or whether they cause the release of some endogenous emetic fact
ors. In order to elucidate whether 5-hydroxytryptamine (5-HT) is relea
sed from the gut mucosa following cyclophosphamide administration, the
urinary excretion of 5-hydroxyindole acetic acid (5-HIAA) was investi
gated in rats. Chronic administration of cyclophosphamide (4 weeks x 1
0 mg/kg, i.p.) significantly increased urinary 5-HIAA excretion in rat
. There were no significant abnormal values in terms of s-GOT, GPT or
LDH. The histopathology studies revealed only marginal changes to the
mucosa in the rat intestine. It is concluded that the increased amount
of 5-HIAA in rat urine induced by cyclophosphamide was derived from d
egranulated 5-HT from EC cells in the gut mucosa This provides further
support for the hypothesis that 5-HT is involved in cyclophosphamide-
induced emesis in emetic species.